Acquired resistance to NTRK inhibitors and development of inhibitors targeting resistance mutations


18 Sep 2019


Session 6 Clinical development of NTRK inhibitors (Part 2)


U. Lassen, DK

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings